Literature DB >> 21799436

Initiating antiretroviral therapy in pregnancy: the importance of timing.

Landon Myer.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21799436     DOI： 10.1097/QAI.0b013e31822ad573

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  10 in total

1.  Cost-effectiveness of a package of interventions for expedited antiretroviral therapy initiation during pregnancy in Cape Town, South Africa.

Authors:  Rose Zulliger; Samantha Black; David R Holtgrave; Andrea L Ciaranello; Linda-Gail Bekker; Landon Myer
Journal:  AIDS Behav       Date:  2014-04

2.  Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa.

Authors:  Karl-Günter Technau; Emma Kalk; Ashraf Coovadia; Vivian Black; Sam Pickerill; Claude A Mellins; Elaine J Abrams; Renate Strehlau; Louise Kuhn
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

3.  Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa.

Authors:  Landon Myer; Tamsin Phillips; Victoria Manuelli; James McIntyre; Linda-Gail Bekker; Elaine J Abrams
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-26       Impact factor: 3.731

4.  Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.

Authors:  Eva M Rempis; Alexandra Schnack; Sarah Decker; Vera Braun; John Rubaihayo; Nazarius Mbona Tumwesigye; Priscilla Busingye; Gundel Harms; Stefanie Theuring
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-07       Impact factor: 3.007

5.  A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT).

Authors:  Bruce A Larson; Nafisa Halim; Isaac Tsikhutsu; Margaret Bii; Peter Coakley; Peter C Rockers
Journal:  Glob Health Res Policy       Date:  2019-10-15

6.  Testing strategies for couple engagement in prevention of mother-to-child transmission of HIV and family health in Kenya: study protocol for a randomized controlled trial.

Authors:  Zachary Kwena; Liza Kimbo; Lynae A Darbes; Abigail M Hatcher; Anna Helova; George Owino; Harsha Thirumurthy; Elizabeth A Bukusi; Thomas Braun; Meredith Kilgore; Maria Pisu; Ashutosh Tamhane; Van T Nghiem; Kawango Agot; Torsten B Neilands; Janet M Turan
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

7.  Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study.

Authors:  Landon Myer; Rose Zulliger; Linda-Gail Bekker; Elaine Abrams
Journal:  BMC Pregnancy Childbirth       Date:  2012-09-11       Impact factor: 3.007

8.  Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: a cohort study.

Authors:  Kathryn Stinson; Karen Jennings; Landon Myer
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.

Authors:  Landon Myer; Kristen Daskilewicz; James McIntyre; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2013-09-16       Impact factor: 5.396

10.  Patient factors to target for elimination of mother-to-child transmission of HIV.

Authors:  Coceka N Mnyani; Adonia Simango; Joshua Murphy; Matthew Chersich; James A McIntyre
Journal:  Global Health       Date:  2014-05-15       Impact factor: 4.185
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.